收费全文 | 2620936篇 |
免费 | 166043篇 |
国内免费 | 7371篇 |
耳鼻咽喉 | 34517篇 |
儿科学 | 85511篇 |
妇产科学 | 71668篇 |
基础医学 | 364963篇 |
口腔科学 | 70062篇 |
临床医学 | 235825篇 |
内科学 | 518435篇 |
皮肤病学 | 62660篇 |
神经病学 | 215030篇 |
特种医学 | 100274篇 |
外国民族医学 | 736篇 |
外科学 | 388400篇 |
综合类 | 50502篇 |
现状与发展 | 5篇 |
一般理论 | 993篇 |
预防医学 | 197221篇 |
眼科学 | 56971篇 |
药学 | 188918篇 |
66篇 | |
中国医学 | 5356篇 |
肿瘤学 | 146237篇 |
2021年 | 20585篇 |
2019年 | 21492篇 |
2018年 | 29512篇 |
2017年 | 22758篇 |
2016年 | 26471篇 |
2015年 | 29686篇 |
2014年 | 40677篇 |
2013年 | 60815篇 |
2012年 | 80642篇 |
2011年 | 84945篇 |
2010年 | 51278篇 |
2009年 | 49408篇 |
2008年 | 79492篇 |
2007年 | 84333篇 |
2006年 | 86024篇 |
2005年 | 82195篇 |
2004年 | 79156篇 |
2003年 | 76486篇 |
2002年 | 73745篇 |
2001年 | 128491篇 |
2000年 | 131409篇 |
1999年 | 110588篇 |
1998年 | 31341篇 |
1997年 | 28010篇 |
1996年 | 28294篇 |
1995年 | 27447篇 |
1994年 | 25127篇 |
1993年 | 23478篇 |
1992年 | 85213篇 |
1991年 | 81612篇 |
1990年 | 78861篇 |
1989年 | 76130篇 |
1988年 | 69530篇 |
1987年 | 68036篇 |
1986年 | 63589篇 |
1985年 | 60554篇 |
1984年 | 45005篇 |
1983年 | 37993篇 |
1982年 | 22520篇 |
1981年 | 20070篇 |
1979年 | 39008篇 |
1978年 | 27480篇 |
1977年 | 23302篇 |
1976年 | 21545篇 |
1975年 | 22858篇 |
1974年 | 26828篇 |
1973年 | 25412篇 |
1972年 | 23783篇 |
1971年 | 21993篇 |
1970年 | 20206篇 |
Method: A pre-test post-test group design was used to evaluate the effectiveness of the program. Four schools in metropolitan Western Australia were randomly assigned to either the control or experimental condition within a parallel groups design. The control group participated in an alternative program matched for duration and frequency, targeting semantics and grammar.
Result: The children in the experimental condition improved significantly more in PA, alphabet knowledge and non-word reading, and spelling after intervention than the control group.
Conclusion: These findings demonstrate that classroom-based, teacher-delivered PA and alphabet knowledge instruction can be effective for 3;8–5;4 year-olds. 相似文献
Background
Spontaneous decolonization of antibiotic-resistant bacteria (ARB) takes time: approximately 25% after 30 days for carbapenem-producing Enterobacteriaceae or extended-spectrum beta-lactamase-producing Enterobacteriaceae. Faecal microbiota transplantation (FMT) has been proposed as a new strategy to promote decolonization in order to reduce the risk of superinfection due to these ARB. This paper discusses the literature on the use of FMT for this indication, and the improvement levers available to promote its efficacy.Methods
Literature available to date concerning the use of FMT to eradicate ARB was reviewed, and the different factors that may have influenced the efficacy of decolonization were evaluated.Results
Four axes that could have played major roles in the efficacy of FMT were identified: bowel preparation before FMT; donor; dose; and thermal conditioning of faeces. The positive or negative impact of each on the outcome of FMT is discussed.Conclusion
Although FMT is very efficient for the eradication of Clostridium difficile, the same ‘recipe’ cannot be used for the eradication of ARB. Working together with expert centres may help to improve the efficacy of FMT for this indication, and enable the reduction of in-hospital isolation precautions. 相似文献Objectives
Triazole resistance in Aspergillus spp. is emerging and complicates prophylaxis and treatment of invasive aspergillosis (IA) worldwide. New polymerase chain reaction (PCR) tests on broncho-alveolar lavage (BAL) fluid allow for detection of triazole resistance at a genetic level, which has opened up new possibilities for targeted therapy. In the absence of clinical trials, a modelling study delivers estimates of the added value of resistance detection with PCR, and which empiric therapy would be optimal when local resistance rates are known.Design
A decision-analytic modelling study was performed based on epidemiological data of IA, extended with estimated dynamics of resistance rates and treatment effectiveness. Six clinical strategies were compared that differ in use of PCR diagnostics (used vs not used) and in empiric therapeutic choice in case of unknown triazole susceptibility: voriconazole, liposomal amphotericin B (LAmB) or both. Outcome measures were proportion of correct treatment, survival and serious adverse events.Results
Implementing aspergillus PCR tests was projected to result in residual treatment-susceptibility mismatches of <5% for a triazole resistance rate up to 20% (using voriconazole). Empiric LAmB outperformed voriconazole at resistance rates >5–20%, depending on PCR use and estimated survival benefits of voriconazole over LAmB. Combination therapy of voriconazole and LAmB performed best at all resistance rates, but the advantage over the other strategies should be weighed against the expected increased number of drug-related serious adverse events. The advantage of combination therapy over LAmB monotherapy became smaller at higher triazole resistance rates.Conclusions
Introduction of current aspergillus PCR tests on BAL fluid is an effective way to increase the proportion of patients that receive targeted therapy for IA. The results indicate that close monitoring of background resistance rates and adverse drug events are important to attain the potential benefits of LAmB. The choice of strategy ultimately depends on the probability of triazole resistance, the availability of PCR and individual patient characteristics. 相似文献- Download : Download high-res image (131KB)
- Download : Download full-size image
- Download : Download high-res image (451KB)
- Download : Download full-size image
To determine frequencies, interlaboratory reproducibility, clinical ratings, and prognostic implications of neural antibodies in a routine laboratory setting in patients with suspected neuropsychiatric autoimmune conditions.
MethodsEarliest available samples from 10,919 patients were tested for a broad panel of neural antibodies. Sera that reacted with leucine-rich glioma-inactivated protein 1 (LGI1), contactin-associated protein-2 (CASPR2), or the voltage-gated potassium channel (VGKC) complex were retested for LGI1 and CASPR2 antibodies by another laboratory. Physicians in charge of patients with positive antibody results retrospectively reported on clinical, treatment, and outcome parameters.
ResultsPositive results were obtained for 576 patients (5.3%). Median disease duration was 6 months (interquartile range 0.6–46 months). In most patients, antibodies were detected both in CSF and serum. However, in 16 (28%) patients with N-methyl-d-aspartate receptor (NMDAR) antibodies, this diagnosis could be made only in cerebrospinal fluid (CSF). The two laboratories agreed largely on LGI1 and CASPR2 antibody diagnoses (κ = 0.95). The clinicians (413 responses, 71.7%) rated two-thirds of the antibody-positive patients as autoimmune. Antibodies against the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR), NMDAR (CSF or high serum titer), γ-aminobutyric acid-B receptor (GABABR), and LGI1 had ≥ 90% positive ratings, whereas antibodies against the glycine receptor, VGKC complex, or otherwise unspecified neuropil had ≤ 40% positive ratings. Of the patients with surface antibodies, 64% improved after ≥ 3 months, mostly with ≥ 1 immunotherapy intervention.
ConclusionsThis novel approach starting from routine diagnostics in a dedicated laboratory provides reliable and useful results with therapeutic implications. Counseling should consider clinical presentation, demographic features, and antibody titers of the individual patient.
相似文献